Drugs / Live attenuated influenza vaccine (LAIV)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03735147 | Oct 2018 → Apr 2019 | — | Imperial College London | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Live attenuated influenza vaccine (LAIV) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03735147 ↗ |
| Modality | Vaccine | “Live attenuated influenza vaccine (LAIV)” NCT03735147 ↗ |